Discover if semaglutide is right for you and join thousands of Nevada residents whove transformed their lives
KLOW is for research purposes only and is not intended for human or animal use, diagnosis, treatment, or consumption
Here is the practical reality
available only through 503A compounding pharmacies under physician supervision Typical research dose range / 200-800 mcg/day subcutaneously, cycled 4-8 weeks Known lethal dose (LD50) / Not established in any species studied to date Rodent acute toxicity ceiling / No mortality observed at doses exceeding 10 mg/kg intraperitoneally Most reported excess-dose symptoms / Nausea, lightheadedness, flushing, injection-site irritation Organ toxicity at supratherapeutic doses / Not demonstrated in published preclinical literature Antidote availability / No specific antidote exists
Appetite changes with treatment often develop gradually rather than instantly
Your treatment plan Treatment often begins with Tier 1 and may be adjusted over time based on your progress, goals, and clinician guidance
